Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 863 record(s)

Req # A-2020-000004

Adverse Reaction Reports (AERs) for DOCETAXEL. Report numbers: 726219, E2B_02543644, E2B_02557989, E2B_02558001, E2B_02594209, E2B_01762034, E2B_02600757, E2B_02627199, E2B_02630155, E2B_02634430, E2B_02641147.

Organization: Health Canada

138 page(s)
March 2021

Req # A-2020-000028

Adverse Reaction Reports (AERs). Report numbers: E2B_01955068, 000711155, 000728096, 000728829, E2B_02723478, E2B_02764471, E2B_01963121, E2B_02774293, E2B_02780298, E2B_02791294.

Organization: Health Canada

184 page(s)
March 2021

Req # A-2020-000040

Adverse Reaction Reports (AERs). Report numbers: E2B_02935664, E2B_02968785, E2B_02989441, E2B_02935144, E2B_02960895, E2B_02956411, E2B_02966407, E2B_02981231, E2B_02989560, E2B_02960909, E2B_02934111, E2B_02970340, E2B_02935688, E2B_02953752, E2B_02956394, E2B_02970445.

Organization: Health Canada

238 page(s)
March 2021

Req # A-2020-000140

Adverse Reaction Reports (AERs). Report numbers: E2B_02963088, E2B_02963103, E2B_02963105, E2B_02963321.

Organization: Health Canada

50 page(s)
March 2021

Req # A-2020-000197

Adverse Drug Reaction (ADR). Report number: E2B_02610584.

Organization: Health Canada

16 page(s)
March 2021

Req # A-2020-000219

Adverse Reaction Reports (AERs) for ISENTRESS. Report numbers: E2B_00336413, 000676059, 000676060.

Organization: Health Canada

30 page(s)
March 2021

Req # A-2020-000226

Adverse Reaction Reports (AERs) for NASONEX. Report numbers: E2B_00337420, E2B_00338336, 000653339, 000670364, E2B_00542181, 000672686, E2B_00676666, E2B_00421946, E2B_00818817, E2B_00317517, E2B_00803713, 000664071, 000673054, E2B_00797172, E2B_00572127, 000308092, E2B_00859292, E2B_00865616.

Organization: Health Canada

611 page(s)
March 2021

Req # A-2020-000241

Adverse Reaction Reports (AERs) for ZENHALE. Report numbers: 000546550, E2B_00037157, E2B_00282538, E2B_00356618, E2B_01322347, E2B_01490363, E2B_01907640.

Organization: Health Canada

2742 page(s)
March 2021

Req # A-2020-000250

Adverse Reaction Reports (AERs) for FUROSEMIDE. Report numbers: E2B_02714932, E2B_02698395, E2B_02669273, E2B_02760580, E2B_02736554, E2B_02673074, E2B_02769575, E2B_02643642, E2B_02721613, E2B_02758498, E2B_02115509, E2B_02745409, E2B_02703856.

Organization: Health Canada

401 page(s)
March 2021

Req # A-2020-000251

Adverse Reaction Reports (AERs) for HYDROXYCHLOROQUINE SULFATE. Report numbers: E2B_02796933, E2B_02753830, E2B_02794433.

Organization: Health Canada

68 page(s)
March 2021
Date modified: